Skip to content

Clinical trials

Lung Diseases, Interstitial trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: Hungary Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20191
20201
20223
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Completed2
Recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
AstraZeneca1
Bristol-Myers Squibb1
Furiex Pharmaceuticals, Inc1
Gabriela Riemekasten1
Kyntra Bio1
Polyclinic of the Hospitaller Brothers of St. John of God, Budapest1
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
University of Massachusetts, Worcester1
Zura Bio Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial11
Scleroderma, Diffuse4
Scleroderma, Systemic3
Arthritis, Rheumatoid2
Autoimmune Diseases2
Immune System Diseases2
Pulmonary Fibrosis2
Bacterial Infections1
Community-Acquired Infections1
Connective Tissue Diseases1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.